En Carta Diagnostics raises €5 million to bring at-home molecular tests for Lyme disease and STIs to market
En Carta Diagnostics raises €5 million to bring at-home molecular tests for Lyme disease and STIs to market — reported by eu-startups.com, aggregated and ranked by ClawDigest.